Francesca Daniel

545 total citations
21 papers, 180 citations indexed

About

Francesca Daniel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Francesca Daniel has authored 21 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Francesca Daniel's work include Colorectal Cancer Treatments and Studies (14 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Genetic factors in colorectal cancer (4 papers). Francesca Daniel is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Genetic factors in colorectal cancer (4 papers). Francesca Daniel collaborates with scholars based in Italy, France and United States. Francesca Daniel's co-authors include Sara Lonardi, A. Milani, Filippo Pietrantonio, Paolo Manca, Angelo Vanzulli, Francesca Bergamo, Valter Torri, Silvia Marsoni, Daniele Rossini and Andrea Sartore‐Bianchi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Francesca Daniel

17 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Daniel Italy 7 123 68 59 56 29 21 180
Carole A. Harris Australia 6 134 1.1× 50 0.7× 28 0.5× 72 1.3× 43 1.5× 21 183
Riham Katkhuda United States 6 150 1.2× 41 0.6× 68 1.2× 65 1.2× 42 1.4× 15 197
Zorka Inić Serbia 5 92 0.7× 69 1.0× 24 0.4× 29 0.5× 55 1.9× 16 183
D. Páez López-Bravo Spain 5 148 1.2× 39 0.6× 50 0.8× 58 1.0× 77 2.7× 10 204
Federica Villa Italy 7 190 1.5× 81 1.2× 29 0.5× 77 1.4× 47 1.6× 16 225
Thomas Göhler Germany 10 132 1.1× 56 0.8× 28 0.5× 67 1.2× 39 1.3× 34 225
Daniele Rizzi Italy 5 136 1.1× 90 1.3× 59 1.0× 95 1.7× 18 0.6× 15 184
J.C. Ruffinelli Spain 9 180 1.5× 45 0.7× 59 1.0× 102 1.8× 90 3.1× 27 271
Kanwal Pratap Singh Raghav United States 5 163 1.3× 41 0.6× 68 1.2× 117 2.1× 19 0.7× 8 245
Lina Inagaki Japan 7 165 1.3× 40 0.6× 38 0.6× 87 1.6× 54 1.9× 14 327

Countries citing papers authored by Francesca Daniel

Since Specialization
Citations

This map shows the geographic impact of Francesca Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Daniel more than expected).

Fields of papers citing papers by Francesca Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Daniel. The network helps show where Francesca Daniel may publish in the future.

Co-authorship network of co-authors of Francesca Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Daniel. A scholar is included among the top collaborators of Francesca Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Daniel. Francesca Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fanotto, V., Daniele Rossini, Mariaelena Casagrande, et al.. (2023). Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies. Cancers. 15(22). 5451–5451. 1 indexed citations
2.
Marmorino, Federica, Gianmarco Piccinno, Daniele Rossini, et al.. (2023). Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study.. Journal of Clinical Oncology. 41(16_suppl). 3534–3534. 2 indexed citations
3.
Moretto, Roberto, Marco Maria Germani, Javier Ros, et al.. (2023). Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy. JCO Precision Oncology. 7(7). e2300255–e2300255. 5 indexed citations
4.
Prete, Alessandra Anna, Rossana Intini, Valentina Angerilli, et al.. (2023). Immunotherapy in RAS mutant mCRC: Could CTLA-4 blockade increase the efficacy of anti PD-1 agents? Preliminary clinical results of the NERDY study.. Journal of Clinical Oncology. 41(4_suppl). 218–218. 1 indexed citations
5.
Boccaccino, Alessandra, Daniele Rossini, Alessandra Raimondi, et al.. (2023). Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials. European Journal of Cancer. 189. 112910–112910. 2 indexed citations
6.
Bergamo, Francesca, Eleonora Bergo, Francesca Daniel, et al.. (2022). The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer. European Journal of Cancer. 177. 112–119. 4 indexed citations
7.
Dell’Aquila, Emanuela, Daniele Rossini, Marco Stellato, et al.. (2022). Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO. Clinical Colorectal Cancer. 21(3). 220–228. 6 indexed citations
8.
Daniel, Francesca, et al.. (2022). HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target. American Society of Clinical Oncology Educational Book. 42(42). 219–232. 65 indexed citations
9.
Bergamo, Francesca, Antonella Brunello, Giuseppe Sergi, et al.. (2022). 399P Role of geriatric assessment and oncological multidimensional prognostic index in elderly patients with metastatic colorectal cancer in a real-world setting. Annals of Oncology. 33. S719–S719.
10.
11.
Bergamo, Francesca, Francesca Daniel, Cosimo Rasola, et al.. (2021). A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study. Cancers. 13(20). 5128–5128. 12 indexed citations
12.
13.
Rossini, Daniele, Alessandra Boccaccino, Andrea Sbrana, et al.. (2021). Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO. ESMO Open. 6(6). 100293–100293. 3 indexed citations
14.
Sartore‐Bianchi, Andrea, Filippo Pietrantonio, Sara Lonardi, et al.. (2021). Phase II study of anti-EGFR rechallenge therapy with panitumumab driven by circulating tumor DNA molecular selection in metastatic colorectal cancer: The CHRONOS trial.. Journal of Clinical Oncology. 39(15_suppl). 3506–3506. 47 indexed citations
15.
Murgioni, Sabina, Sara Lonardi, Francesca Daniel, et al.. (2019). Ramucirumab: the long and winding road toward being an option for mCRC treatment. Expert Opinion on Biological Therapy. 19(5). 399–409. 9 indexed citations
16.
Daniel, Francesca, et al.. (2017). The regorafenib issue: focus on efficacy and safety in pre-treated metastatic colorectal cancer from a real world experience. Annals of Oncology. 28. vi15–vi16. 1 indexed citations
17.
Daniel, Francesca, Lorenzo Belluomini, Luca Martella, et al.. (2016). Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?. Annals of Oncology. 27. iv116–iv116.
18.
Aiello, Antonella, et al.. (2015). A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy. Value in Health. 18(7). A424–A424. 6 indexed citations
19.
Aiello, Antonella, et al.. (2015). Cost-Effectiveness Of Nilotinib In Patients With Chronic Myeloid Leukaemia Eligible To Start The Treatment-Free Remission Phase In Italy. Value in Health. 18(7). A457–A457. 4 indexed citations
20.
Galiano, Antonella, Francesca Daniel, M. Polacco, et al.. (2014). Safety and Efficacy of Transcatheter Arterial Chemoembolization (Tace) in Unresectable Biliary Cancer. Annals of Oncology. 25. iv246–iv246.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole A. Harris Breakdown of academic impact, for papers by Riham Katkhuda Breakdown of academic impact, for papers by Zorka Inić Breakdown of academic impact, for papers by D. Páez López-Bravo Breakdown of academic impact, for papers by Federica Villa Breakdown of academic impact, for papers by Thomas Göhler Breakdown of academic impact, for papers by Daniele Rizzi Breakdown of academic impact, for papers by J.C. Ruffinelli Breakdown of academic impact, for papers by Kanwal Pratap Singh Raghav Breakdown of academic impact, for papers by Lina Inagaki
Rankless by CCL
2026